Genmab A/S – State Reviewer

Stock Earnings

US Market Shows Favorable Response To Genmab (GMAB) Performance

Genmab A/S (NASDAQ: GMAB) shares are witnessing an upward surge on the US market today, displaying a noteworthy increase of 5.97% to $29.37 as per

Markets

Genmab A/S (NASDAQ:GMAB): A Fundamentally Weighted Stock for Long-Term Investors

Genmab A/S (NASDAQ:GMAB) shares traded lower over the last trading session, losing -1.40% on 06/18/21. The shares fell to a low of $42.80 before closing

Markets

Genmab A/S (GMAB) Tending Higher: Checkout the Key Metrics

Genmab A/S (NASDAQ:GMAB) previous close was $44.02 while the outstanding shares total 653.55M. GMAB’s shares traded higher over the last trading session, gaining 1.25% on

Industry

Analyst’s Sets Genmab A/S (NASDAQ:GMAB) New Target at $42.21: GMAB is Now On A Buy List

Genmab A/S (NASDAQ:GMAB) shares fell to a low of $42.45 before closing at $42.73. Intraday shares traded counted 0.59 million, which was -29.16% lower than

Companies

Something To Watch Before Buying Genmab A/S (NASDAQ:GMAB)

Genmab A/S (NASDAQ:GMAB) Relative Strength Index (RSI) is 73.75, with weekly volatility at 1.59% and ATR at 0.79. The GMAB stock’s 52-week price range has

Tag: Genmab A/S

US Market Shows Favorable Response To Genmab (GMAB) Performance

Genmab A/S (NASDAQ:GMAB): A Fundamentally Weighted Stock for Long-Term Investors

Genmab A/S (GMAB) Tending Higher: Checkout the Key Metrics

Analyst’s Sets Genmab A/S (NASDAQ:GMAB) New Target at $42.21: GMAB is Now On A Buy List

Something To Watch Before Buying Genmab A/S (NASDAQ:GMAB)

Quick Links

Categories